𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension

✍ Scribed by Stumpe, K. O. ;Overlack, A. ;Kolloch, R. ;Schatz, J. ;Witte, P. U. ;Pahnke, K.

Publisher
Springer-Verlag
Year
1986
Tongue
English
Weight
552 KB
Volume
64
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Metabolic effects of long-term angiotens
Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition
✍ R. Reneland; P.-E. Andersson; A. Haenni; H. Lithell πŸ“‚ Article πŸ“… 1994 πŸ› Springer 🌐 English βš– 566 KB

Fifty patients with mild to moderate essential hypertension were randomized to receive either 20 mg fosinopril daily for 16 weeks or placebo for 4 weeks followed by 12 weeks of 50 mg atenolol daily. Prior to these 16 weeks there was a placebo wash-out period of 2-6 weeks. Blood pressure measurements